Zhou F, Yang G, Xue L, Liu Y, et al. SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models. Breast Cancer Res 2023;25:96.
PMID: 37580832